Prior onabotulinumtoxin-A improves subsequent anti-CGRP mAb response in chronic migraineDecember 19, 2023Headache & Migraine
Galcanezumab effective for migraine prevention in women with menstrually related migraineDecember 19, 2023Headache & Migraine
Fremanezumab offers a safe and effective long-term treatment option for drug-resistant migraineDecember 19, 2023Headache & Migraine
Fremanezumab is effective and safe for migraine prevention under real-world conditionsDecember 19, 2023Headache & Migraine
Sustained migraine prevention with eptinezumab in initial non-respondersDecember 19, 2023Headache & Migraine
Ubrogepant effective and safe for migraine treatment during prodromeDecember 19, 2023Headache & Migraine
Commentary: CGRP Monoclonal Antibodies for Migraine, December 2023December 11, 2023Headache & Migraine
Drugs to prevent versus those to treat migraine might not share targetsNovember 28, 2023Headache & Migraine
Real-world study confirms benefits of erenumab for migraine preventionNovember 22, 2023Headache & Migraine
Heavy secondhand smoke exposure tied to higher risk for severe headaches or migraineNovember 22, 2023Headache & Migraine
Heart rate variability may help predict treatment response in chronic migraineNovember 22, 2023Headache & Migraine
Remote electrical neuromodulation: A pill-free, needle-free option for long-term migraine managementNovember 22, 2023Headache & Migraine
Ubrogepant and anti-CGRP mAb combo is effective for acute treatment of migraineNovember 22, 2023Headache & Migraine
